Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus

A. Skrahina (Minsk, Belarus), N. Yatskevich (Minsk, Belarus), H. Hurevich (Minsk, Belarus), V. Grankov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), A. Skrahin (MInsk, Belarus), E. Gurbanova (Tartu, Estonia), M. Dara (Copenhagen, Denmark)

Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session: Multidrug-resistant tuberculosis
Session type: E-poster session
Number: 1591
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahina (Minsk, Belarus), N. Yatskevich (Minsk, Belarus), H. Hurevich (Minsk, Belarus), V. Grankov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), A. Skrahin (MInsk, Belarus), E. Gurbanova (Tartu, Estonia), M. Dara (Copenhagen, Denmark). Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus. 1591

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: